Coenzymeq10 (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 21 | Mitochondrial disease | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00432744 (ClinicalTrials.gov) | January 2007 | 6/2/2007 | Phase III Trial of Coenzyme Q10 in Mitochondrial Disease | Phase 3 Trial of Coenzyme Q10 in Mitochondrial Disease | Mitochondrial Diseases | Drug: CoenzymeQ10;Drug: Placebo | University of Florida | FDA Office of Orphan Products Development;Food and Drug Administration | Completed | 12 Months | 17 Years | All | 24 | Phase 3 | United States;Canada |